JUN and cancer: Existing literature has highlighted that the YAP/PDZ‐binding motif (TAZ)/TEAD interacts with AP‐1 to facilitate tumour growth,11 while inhibition of YAP/TAZ‐TEAD has recently emerged as a promising therapeutic target for various types of cancers.4